Moreover, a previous study on postmortem AD patients revealed an increase in Epac1 and a decrease in Epac2 at the mRNA level [15], further pinning the two isoforms to differential contributions to neurodegeneration. This evidence concerns the gene RAPGEF3 and Alzheimer disease.